Market Overview

UPDATE: Goldman Sachs Downgrades CME Group to Sell on EPS Risk

Related CME
Benzinga's Weekend M&A Chatter
Keefe, Bruyette & Woods Changes Ratings And Targets On Exchange Stocks
CME Glitch Halts Electronic Trading in Some Commodities (Fox Business)

Goldman Sachs reduced its rating on CME Group (NASDAQ: CME) from Neutral to Sell and reduced its price target from $53 to $48.

Goldman Sachs noted, "Although we view CME as the leading global futures exchange, with resilient margins and a powerful capital deployment strategy, we believe the Street is too optimistic on CME's near-term EPS outlook (we are 8% below consensus for 2013) given the most recent volume and open interest trends. Moreover, following CME's recent variable dividend announcement on 12/5/2012, we expect investor focus could shift back to the firm's core fundamentals, which continue to deteriorate with total open interest down 12% yoy through November."

CME Group closed at $54.96 on Friday.

Latest Ratings for CME

DateFirmActionFromTo
Dec 2014Deutsche BankMaintainsBuy
Dec 2014Keefe Bruyette & WoodsDowngradesOutperformMarket Perform
Oct 2014CitigroupMaintainsNeutral

View More Analyst Ratings for CME
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (CME)

Around the Web, We're Loving...

Get Benzinga's Newsletters